Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Paoletti

Showing results (31-40 of 229) with videos related to

Pageof 23
Sort By:
FEBS Letters|October 1, 1971
A new DNA intercalating drug: Methoxy-9-ellipticineB Festy, J Poisson, C Paoletti
Biochemical Pharmacology|June 15, 1982
Mitochondrial and nuclear mutagenicity of ellipticine and derivatives in the yeast Saccharomyces cerevisiaeM Pinto, M Guerineau, C Paoletti
Journal of Chromatography. A|June 30, 1995
Purification of preparative quantities of group B Streptococcus type III oligosaccharidesL C Paoletti, K D Johnson
Expert Opinion on Biological Therapy|August 29, 2003
Glycoconjugate vaccines to prevent group B streptococcal infectionsLawrence C Paoletti, Dennis L Kasper
Mutation Research|May 1, 1988
Frameshift lesions induced by oxazolopyridocarbazoles are recognized by the mismatch repair system in Escherichia coliB René, C Auclair, C Paoletti
Seminars in Neonatology : SN|October 29, 2002
Vaccines to prevent neonatal GBS infectionLawrence C Paoletti, Lawrence C Madoff
Mutation Research|November 1, 1975
Ethidium bromide mutagenesis in yeast: protection by anaerobiosisM Pinto, M Guerineau, C Paoletti
Biochemical and Biophysical Research Communications|October 30, 1984
Covalent binding of the antitumor agent N2-methyl-9-hydroxy-ellipticinium acetate (NSC 264137) on RNA and poly A in vitroB Dugue, C Paoletti, B Meunier
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1972
Circular oligomers in mitochondrial DNA of human and beef nonmalignant thyroid glandsC Paoletti, G Riou, J Pairault
The Journal of Infectious Diseases|June 29, 2002
Conjugate vaccines against group B Streptococcus types IV and VIILawrence C Paoletti, Dennis L Kasper
Pageof 23

Showing results (31-40 of 229) with videos related to

Sort By:
Pageof 23
FEBS Letters|October 1, 1971
A new DNA intercalating drug: Methoxy-9-ellipticineB Festy, J Poisson, C Paoletti
Biochemical Pharmacology|June 15, 1982
Mitochondrial and nuclear mutagenicity of ellipticine and derivatives in the yeast Saccharomyces cerevisiaeM Pinto, M Guerineau, C Paoletti
Journal of Chromatography. A|June 30, 1995
Purification of preparative quantities of group B Streptococcus type III oligosaccharidesL C Paoletti, K D Johnson
Expert Opinion on Biological Therapy|August 29, 2003
Glycoconjugate vaccines to prevent group B streptococcal infectionsLawrence C Paoletti, Dennis L Kasper
Mutation Research|May 1, 1988
Frameshift lesions induced by oxazolopyridocarbazoles are recognized by the mismatch repair system in Escherichia coliB René, C Auclair, C Paoletti
Seminars in Neonatology : SN|October 29, 2002
Vaccines to prevent neonatal GBS infectionLawrence C Paoletti, Lawrence C Madoff
Mutation Research|November 1, 1975
Ethidium bromide mutagenesis in yeast: protection by anaerobiosisM Pinto, M Guerineau, C Paoletti
Biochemical and Biophysical Research Communications|October 30, 1984
Covalent binding of the antitumor agent N2-methyl-9-hydroxy-ellipticinium acetate (NSC 264137) on RNA and poly A in vitroB Dugue, C Paoletti, B Meunier
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1972
Circular oligomers in mitochondrial DNA of human and beef nonmalignant thyroid glandsC Paoletti, G Riou, J Pairault
The Journal of Infectious Diseases|June 29, 2002
Conjugate vaccines against group B Streptococcus types IV and VIILawrence C Paoletti, Dennis L Kasper
Pageof 23